Fischer, Melissa A <br/><br/>
Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies.  [electronic resource] 

 -  Blood advances  02 2020 
 - 586-598 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2473-9537 
<br/><br/><label>Standard No.: </label>10.1182/bloodadvances.2019000359  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Active Transport, Cell Nucleus<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacology<br/>Cell Line, Tumor<br/>Hematologic Neoplasms--drug therapy<br/>Humans<br/>Sulfonamides